companydata.dkNovo Nordisk North America Operations A/S: Financial statements 2016
CVR: 33761201
Novo Nordisk North America Operations A/S (CVR 33761201) has filed annual accounts for 2016. In 2016, the company reported a net result of DKK -5,342,000 compared with DKK -5,714,000 the year before. Equity amounted to DKK 25,060,000. The solvency ratio was 32.5%.
- Profit/Loss
- -5,342,000 kr.
- Equity
- 25,060,000 kr.
- Total Assets
- 77,196,000 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | - | -5.3 mio. | 25.1 mio. | - |
| 2015 | - | - | -5.7 mio. | 40.6 mio. | - |
| 2014 | - | - | -21 t. | 424 t. | - |
| 2013 | - | - | -27 t. | 445 t. | - |
| 2012 | - | - | -17 t. | 472 t. | - |
How creditworthy is Novo Nordisk North America Operations A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
Novo Nordisk North America Operations A/S has published its annual report for 2015. The net result was DKK -5,714,000.
About Novo Nordisk North America Operations A/S
Novo Nordisk North America Operations A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 2011. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named Novo Nordisk Invest 3 A/S and NOVO NORDISK REGION NORTH AMERICA II A/S. The management consists of Anders Rytter Mikkelsen. The company is owned by NOVO NORDISK A/S. In 2025, the company reported a gross profit of DKK -59,000 and a net result of DKK -74,142,000 compared with DKK -89,167,000 the year before. Equity amounted to DKK 60,045,000.